196 related articles for article (PubMed ID: 11299791)
21. [Protein studies in cystic and peritoneal fluids of ovarian tumors with special reference to CEA].
Briese V; Strache RR; Voss P; Kunze M; Büttner HH
Zentralbl Gynakol; 1988; 110(5):291-7. PubMed ID: 3376613
[TBL] [Abstract][Full Text] [Related]
22. Immunoexpression of beta-catenin--E-cadherin complex in primary serous ovarian tumors.
Stawerski P; Wagrowska-Danilewicz M; Stasikowska O; Gottwald L; Danilewicz M
Pol J Pathol; 2008; 59(1):27-32. PubMed ID: 18655368
[TBL] [Abstract][Full Text] [Related]
23. GSTP1-1 in ovarian cyst fluid and disease outcome of patients with ovarian cancer.
Kolwijck E; Zusterzeel PL; Roelofs HM; Hendriks JC; Peters WH; Massuger LF
Cancer Epidemiol Biomarkers Prev; 2009 Aug; 18(8):2176-81. PubMed ID: 19661073
[TBL] [Abstract][Full Text] [Related]
24. E-cadherin expression and bromodeoxyuridine incorporation during development of ovarian inclusion cysts in age-matched breeder and incessantly ovulated CD-1 mice.
Fleming JS; McQuillan HJ; Millier MJ; Beaugié CR; Livingstone V
Reprod Biol Endocrinol; 2007 Apr; 5():14. PubMed ID: 17425809
[TBL] [Abstract][Full Text] [Related]
25. [Sialic acid concentrations in blood samples as well as in cyst and peritoneal fluid in patients with ovarian cysts and cystic ovarian tumors].
Strache RR; Büttner HH; Göcze PM; Briese V
Zentralbl Gynakol; 1990; 112(23):1445-53. PubMed ID: 2291368
[TBL] [Abstract][Full Text] [Related]
26. Comparison of biochemical markers between benign and malignant ovarian cysts.
Knight JA; Wu JT; Miya T; Knight DP
Clin Physiol Biochem; 1986; 4(2):130-5. PubMed ID: 3516514
[TBL] [Abstract][Full Text] [Related]
27. Expression of cadherins and CD44 isoforms in ovarian endometrial cysts.
Daraï E; Leblanc M; Walker-Combrouze F; Bringuier AF; Madelenat P; Scoazec JY
Hum Reprod; 1998 May; 13(5):1346-52. PubMed ID: 9647570
[TBL] [Abstract][Full Text] [Related]
28. ThinPrep evaluation of fluid samples aspirated from cystic ovarian masses.
Lu D; Davila RM; Pinto KR; Lu DW
Diagn Cytopathol; 2004 May; 30(5):320-4. PubMed ID: 15108229
[TBL] [Abstract][Full Text] [Related]
29. Comparative immunohistochemical studies of bcl-2 and p53 proteins in benign and malignant ovarian endometriotic cysts.
Nezhat F; Cohen C; Rahaman J; Gretz H; Cole P; Kalir T
Cancer; 2002 Jun; 94(11):2935-40. PubMed ID: 12115382
[TBL] [Abstract][Full Text] [Related]
30. CA 125 and vascular endothelial growth factor in the differential diagnosis of epithelial ovarian tumors.
Candido Dos Reis F; Moreira de Andrade J; Bighetti S
Gynecol Obstet Invest; 2002; 54(3):132-6. PubMed ID: 12571433
[TBL] [Abstract][Full Text] [Related]
31. Vascular endothelial growth factor in adnexal masses.
Demirkiran F; Kumbak B; Bese T; Arvas M; Benian A; Aydin S; Uzun H; Sanioglu C; Aydinli K; Kösebay D
Int J Gynaecol Obstet; 2003 Oct; 83(1):53-8. PubMed ID: 14511872
[TBL] [Abstract][Full Text] [Related]
32. LDH/L-lactate: NAD+ oxidoreductase (E.C.1.1.1.27) activity in the cystic fluid of benign and malignant ovarian tumours.
Jandová A; Laurová L; Janousková M; Novotná J; Pezlarová J; Skoda V; Trnka V
Acta Univ Carol Med Monogr; 1977; (78 Pt 2):121-3. PubMed ID: 615457
[No Abstract] [Full Text] [Related]
33. Plasma urocortin levels in the diagnosis of ovarian endometriosis.
Florio P; Reis FM; Torres PB; Calonaci F; Toti P; Bocchi C; Linton EA; Petraglia F
Obstet Gynecol; 2007 Sep; 110(3):594-600. PubMed ID: 17766605
[TBL] [Abstract][Full Text] [Related]
34. Elevated serum RANTES levels in patients with ovarian cancer correlate with the extent of the disorder.
Tsukishiro S; Suzumori N; Nishikawa H; Arakawa A; Suzumori K
Gynecol Oncol; 2006 Sep; 102(3):542-5. PubMed ID: 16510173
[TBL] [Abstract][Full Text] [Related]
35. [Determination of N-acetylneuraminic acid for the differential diagnosis of cystic ovarian tumors].
Donat H; Bernstein L; Schenk H; Erbstösser E; Rosé A
Arch Geschwulstforsch; 1989; 59(2):113-20. PubMed ID: 2719531
[TBL] [Abstract][Full Text] [Related]
36. Vascular endothelial growth factor (VEGF) concentration in sera and tumor effusions from patients with ovarian carcinoma.
Harlozinska A; Sedlaczek P; Kulpa J; Grybos M; Wójcik E; Van Dalen A; Einarsson R
Anticancer Res; 2004; 24(2C):1149-57. PubMed ID: 15154640
[TBL] [Abstract][Full Text] [Related]
37. Hepatocyte growth factor (HGF) in ovarian epithelial tumour fluids stimulates the migration of ovarian carcinoma cells.
Sowter HM; Corps AN; Smith SK
Int J Cancer; 1999 Nov; 83(4):476-80. PubMed ID: 10508482
[TBL] [Abstract][Full Text] [Related]
38. Expression of cadherins and catenins correlates with distinct histologic types of ovarian carcinomas.
Sarrió D; Moreno-Bueno G; Sánchez-Estévez C; Bañón-Rodríguez I; Hernández-Cortés G; Hardisson D; Palacios J
Hum Pathol; 2006 Aug; 37(8):1042-9. PubMed ID: 16867867
[TBL] [Abstract][Full Text] [Related]
39. Diffusion-weighted echo-planar MR imaging and ADC mapping in the differential diagnosis of ovarian cystic masses: usefulness of detecting keratinoid substances in mature cystic teratomas.
Nakayama T; Yoshimitsu K; Irie H; Aibe H; Tajima T; Nishie A; Asayama Y; Matake K; Kakihara D; Matsuura S; Nakano H; Honda H
J Magn Reson Imaging; 2005 Aug; 22(2):271-8. PubMed ID: 16028258
[TBL] [Abstract][Full Text] [Related]
40. Measurement of glycodelin A in fluids of benign ovarian cysts, borderline tumours and malignant ovarian cancer.
Bischof A; Briese V; Richter DU; Bergemann C; Friese K; Jeschke U
Anticancer Res; 2005; 25(3A):1639-44. PubMed ID: 16033074
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
